ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
139.90
1.80
(1.30%)
Closed December 28 4:00PM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
139.90
Bid
139.10
Ask
140.65
Volume
4,553
137.10 Day's Range 140.75
136.15 52 Week Range 176.90
Market Cap
Previous Close
138.10
Open
137.15
Last Trade
6
@
139.94999
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,222
Shares Outstanding
129,242,251
Dividend Yield
1.57%
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
20.99B
Net Profit
2.82B

About Merck KGAA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Diversified
Website
Headquarters
Darmstadt, Deu
Founded
1987
Merck KGAA is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker MRK. The last closing price for Merck KGAA was 138.10 €. Over the last year, Merck KGAA shares have traded in a share price range of 136.15 € to 176.90 €.

Merck KGAA currently has 129,242,251 shares outstanding. The market capitalization of Merck KGAA is 17.85 € billion.

MRK Latest News

Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer

New clinical trial supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.Avelumab (BAVENCIO®) to be provided to Imugene for Phase 2 clinical study in HER-2 positive gastric or...

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of 'Precision Medicine in Cancer Ca...

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of 'Precision Medicine in Cancer Care' PR Newswire DARMSTADT, Germany, September 26, 2014 DARMSTADT...

Merck Serono Awards Grant for Growth Innovation (GGI) for the First Time

Merck Serono Awards Grant for Growth Innovation (GGI) for the First Time PR Newswire DARMSTADT, Germany, September 19, 2014 DARMSTADT, Germany, September 19, 2014 /PRNewswire/ -- The first grants...

Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age

Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in Children with PKU Below 4 Years of Age PR Newswire DARMSTADT, Germany, September 3, 2014 DARMSTADT, Germany, September...

Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide

Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China, its Second Largest Worldwide PR Newswire NANTONG, China, August 27, 2014 NANTONG, China, August 27...

Merck Serono Announces FDA Clearance for Auxogyn's Early Embryo Viability Assessment (Eeva®) System

Merck Serono Announces FDA Clearance for Auxogyn's Early Embryo Viability Assessment (Eeva®) System PR Newswire DARMSTADT, Germany, June 10, 2014 DARMSTADT, Germany, June 10, 2014 /PRNewswire/...

EMD Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers

EMD Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers PR Newswire ROCKLAND, Massachusetts, May 29, 2014 ROCKLAND...

Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal

Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal PR Newswire DARMSTADT, Germany and PARIS, April 17, 2014 DARMSTADT, Germany and PARIS, April...

European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors

European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors PR Newswire DARMSTADT, Germany, December 23, 2013 DARMSTADT, Germany...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.31.67151162791137.6140.75136.157776138.13708848DE
4-0.95-0.674476393326140.85146.19999136.1510001140.91240732DE
12-17.25-10.976773783157.15168.1136.159222147.91261027DE
26-14.6-9.4498381877154.5176.9136.157528154.07893268DE
52-2.04999-1.44416353957141.94999176.9136.158255154.6309127DE
156-85-37.7945753668224.9231.5134.35180571173.47582402DE
26034.132.2306238185105.8231.576.22290890148.20524592DE

MRK - Frequently Asked Questions (FAQ)

What is the current Merck KGAA share price?
The current share price of Merck KGAA is 139.90 €
How many Merck KGAA shares are in issue?
Merck KGAA has 129,242,251 shares in issue
What is the market cap of Merck KGAA?
The market capitalisation of Merck KGAA is EUR 17.85B
What is the 1 year trading range for Merck KGAA share price?
Merck KGAA has traded in the range of 136.15 € to 176.90 € during the past year
What is the reporting currency for Merck KGAA?
Merck KGAA reports financial results in EUR
What is the latest annual turnover for Merck KGAA?
The latest annual turnover of Merck KGAA is EUR 20.99B
What is the latest annual profit for Merck KGAA?
The latest annual profit of Merck KGAA is EUR 2.82B
What is the registered address of Merck KGAA?
The registered address for Merck KGAA is FRANKFURTER STRASSE 250, DARMSTADT, 64293
What is the Merck KGAA website address?
The website address for Merck KGAA is www.merck.de
Which industry sector does Merck KGAA operate in?
Merck KGAA operates in the PHARMACEUTICAL DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
Z4UreAlpha Tech Corp
2.60 €
(114.70%)
8.05k
510Graphex Group Limited
0.392 €
(106.32%)
16.46k
34Q0Quantum eMotion Inc
0.73 €
(103.91%)
2.99M
M000Vertical Aerospace Ltd
14.50 €
(101.39%)
8.16k
2WOWide Open Agriculture Ltd
0.01 €
(100.00%)
18k
ANLAnalog Devices Inc
9.6728 €
(-95.32%)
1.25k
E3O1Nexoptic Technology Corp
0.007 €
(-62.16%)
12.62k
WWTWater Ways Technologies Inc
0.003 €
(-50.00%)
181.5k
1RR1Rokmaster Resources Corp
0.006 €
(-50.00%)
19k
7CCCheckCap Ltd
1.14 €
(-47.22%)
265
PF8European Lithium Limited
0.024 €
(18.81%)
14.01M
D7GNel ASA
0.2429 €
(-3.07%)
5.39M
RQ0DWave Quantum Inc
9.474 €
(21.03%)
3.1M
34Q0Quantum eMotion Inc
0.73 €
(103.91%)
2.99M
M11First Graphene Limited
0.019 €
(4.40%)
2.5M

Discussion

View Full Feed
JamesF1 JamesF1 33 seconds ago
I found the 2017 market size (93 million). My guess is it’s larger now. https://investors.amneal.com/news/press-releases/press-release-details/2017/Impax-Announces-FDA-Approval-and-Launch-of-Additional-Strengths-of-Generic-Focalin-XR-Dexmethylphenidate-Hydrochloride-Extended-Release-Capsules-CII/de
ELTP
cojoboy cojoboy 40 seconds ago
Where in like..3 of these plays My Bro..????...only need (1) to hit..but..all (3)..oh..lal.lay.lay.😂😂😂
RDAR
Huggy Bear Huggy Bear 51 seconds ago
No can do.

Retailers should be scared of these con artists.

If you want a boiler room echo chamber, go find one. Plenty exist out there.

This ain't it.
HMBL
TenKay TenKay 55 seconds ago
The company filings should be all that an investor relies on. If it’s not in a filing it really doesn’t matter.

As for the “patent”. The OTC is rife with “patent” plays.

95% of issued patents are never successfully commercialized.

But then HMBL sharehol
HMBL
NeoSunTzu NeoSunTzu 2 minutes ago
You are correct that Navy is just posting things as your stated reasons, but let's be clear about a few things: all of my statements regarding advocacy applied to ROLG, Tim Howard and others NOT Navy. In any case, I do NOT think it is a good idea to keep spreading the pieces of those like ROLG who k
StockHobit StockHobit 2 minutes ago
Yep. 2024 was basically a wash.  Nothing significant at all.  No reason to expect that to change in 2025. 
IBGR
NoMoDo NoMoDo 2 minutes ago
Are you saying that you are incapable of looking for basic information that I have posted as well as the lady on Twitter that actually came up with the $72mil valuation? That doesn't include $1mi for the Avrio stock. It doesn't include the value of HMBL's assets that it sold to WSCG in which HMBL
HMBL
Monksdream Monksdream 2 minutes ago
CGC, new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/12/28/oismkIMG_4272.gif
kthomp19 kthomp19 2 minutes ago
Why do you think that the US Government is entitled to receive more than $500 billion for making a $200 billion commitment available???

1) What you, me, or anyone else here thinks Treasury is "entitled to" means nothing.
2) The commitment was raised to a total of $400B by the
FNMA
kthomp19 kthomp19 3 minutes ago
they should at least read 12 words from the 5th Amendment to the Constitution: "...nor shall private property be taken for private use without just compensation".

https://cafc.uscourts.gov/opinions-orders/20-1912.OPINION.2-22-2022_1911455.pdf The CAFC dismissed all the NWS and cons
FNMA
kthomp19 kthomp19 3 minutes ago
Once free, all funds will be grabbing shares to show their investors how smart they are to own shares in corporations that earn over $15 per share annually.

Just wait until they see the tsunami of supply ready to meet them. They must be giggling with anticipation at Treasury.
FNMA
CherryTree1 CherryTree1 3 minutes ago
If you want to be believed then simply explain how this supposed high roller accumulated 100 million shares and over what time frame.
I'll wait
NWBO
kthomp19 kthomp19 3 minutes ago
Regardless of scenario 1 or 2, you just need to state a % chance that JPS will get 90%+ of par, and then we can sticky this to see how accurate you are.

Your turn. Time to hear your answers to your own questions.

What probability do you give for SPS to be converted to
FNMA
bri123 bri123 3 minutes ago
That would be great.
THBD
kthomp19 kthomp19 3 minutes ago
What I'm hearing you say is:

- 85% chance the seniors are converted to common, and they will take between 90-95% equity
- 15% chance the seniors are not converted, in which case they will use warrants to take 80% equity
- 0% chance that something other than these two sce
FNMA
kthomp19 kthomp19 3 minutes ago
It might as well be a 10.50 wall cuz 3.50 will be a dot in the rearview upon a murmur.

A big enough reverse split would cause the share price to zoom straight past both 3.50 and 10.50.
FNMA
kthomp19 kthomp19 3 minutes ago
AND The Supreme Court basically said we will not rule or give Judgment are act as an arbitrator on the contract the SPSPA.

Wrong. They said that the NWS specifically was not ultra vires, i.e. it was a valid act of a conservator by 12 USC 4617(b)(2)(J)(ii).

So, the NWS w
FNMA
kthomp19 kthomp19 4 minutes ago
Close - I still generally agree with the Ackman model where he says about $47 with the $2B/yr dividend for juniors turned back on.

I am geninuely curious as to why anyone still uses https://www.wsj.com/public/resources/documents/IraSohnAckmanPresentation.pdf that horribly outdated
FNMA
Seminole Red Seminole Red 4 minutes ago
Republicans in Florida have expanded their supermajority in the state House as Democrat Rep. Hillary Cassel announced Friday she was switching her party affiliation to Republican. https://bit.ly/41Pp4Af
PlaySmart2020 PlaySmart2020 4 minutes ago
Huggggy please stop scaring our growing investment:) Come on, be caring and lovely. OTC is all about risk/reward. At least HMBL has moved from 001 to 0046 unlike many other stocks still unmoved from their par value. Myself and many others strongly believe in $HMBL. Stop being negative especially, wh
HMBL
crudeoil24 crudeoil24 4 minutes ago
Any accidents with Tesla pickup trucks?
TSLA
236T568 236T568 4 minutes ago
Things seem to be calming down over there.

https://cdn.bsky.app/img/feed_fullsize/plain/did:plc:apo2t7ketcjpsxsdtrbzhyzo/bafkreibrmol5t2za4inv33b3wn3q524g374wadjfwyk7ynhtm2bv7zzlym@jpeg

https://bsky.app/profile/jack-e-smith.bsky.social/post/3leemxge2uc2y
Myth Myth 5 minutes ago
On The Run - The Jompson Brothers ( Chris Stapleton )

https://www.youtube.com/watch?v=VEjgsMKYOUo
doc2016 doc2016 5 minutes ago
from google notebook lm:"Briefing Document: Patent Trends of IonQ and NVIDIA
This document analyzes recent patents assigned to IonQ, Inc. and NVIDIA Corporation, highlighting key themes and important takeaways.

IonQ, Inc.: Focus on Trapped-Ion Quantum Computing Advancements
API

Your Recent History

Delayed Upgrade Clock